# Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children

> **NCT05053594** · PHASE4 · UNKNOWN · sponsor: **Pontificia Universidade Catolica de Sao Paulo** · enrollment: 60 (estimated)

## Conditions studied

- Neuromuscular Blockade
- Neuromuscular Block, Residual
- Neuromuscular Block Prolonged

## Interventions

- **DRUG:** Neostigmine 10 mcg/kg
- **DRUG:** Neostigmine 20 mcg/kg
- **DRUG:** Neostigmine 30 mcg/kg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05053594
- **Lead sponsor:** Pontificia Universidade Catolica de Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-02-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05053594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05053594, "Different Doses of Neostigmine for Reversal of Moderate Neuromuscular Blockade in Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05053594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*